These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15861719)

  • 1. [RNA-loaded dendritic cells].
    Hinoda Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():613-8. PubMed ID: 15861719
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
    Shurin MR; Gregory M; Morris JC; Malyguine AM
    Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy.
    Hsu AK; Kerr BM; Jones KL; Lock RB; Hart DN; Rice AM
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):855-67. PubMed ID: 16864056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.
    Miura S; Kagamu H; Tanaka H; Yoshizawa H; Gejyo F
    Scand J Immunol; 2008 Apr; 67(4):385-91. PubMed ID: 18282232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
    Grünebach F; Kayser K; Weck MM; Müller MR; Appel S; Brossart P
    Cancer Gene Ther; 2005 Sep; 12(9):749-56. PubMed ID: 15877082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy with mRNA-transfected dendritic cells.
    Gilboa E; Vieweg J
    Immunol Rev; 2004 Jun; 199():251-63. PubMed ID: 15233739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.
    Boczkowski D; Nair SK; Nam JH; Lyerly HK; Gilboa E
    Cancer Res; 2000 Feb; 60(4):1028-34. PubMed ID: 10706120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [mRNA-transfected dendritic cells: a promising strategy in immunotherapy].
    Maisnier-Patin K; Crabé S; Breton G; Dupuy FP; Yassine-Diab B; Sékaly RP
    Med Sci (Paris); 2007 Mar; 23(3):279-84. PubMed ID: 17349289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy.
    Banz A; Cremel M; Rembert A; Godfrin Y
    Vaccine; 2010 Apr; 28(17):2965-72. PubMed ID: 20188177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of cancer using dendritic cells.
    Morse MA; Lyerly HK
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):35-44. PubMed ID: 9557215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor cellular immunotherapy: the breakthrough of dendritic cells].
    Angevin E; André F; Zitvogel L
    Bull Cancer; 2000 Jan; 87(1):107-15. PubMed ID: 10673639
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
    Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
    Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy.
    Bonehill A; Heirman C; Thielemans K
    J Gene Med; 2005 Jun; 7(6):686-95. PubMed ID: 15693037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
    Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular immunotherapy for hematological malignancies].
    Yasukawa M
    Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
    [No Abstract]   [Full Text] [Related]  

  • 17. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.
    Dullaers M; Breckpot K; Van Meirvenne S; Bonehill A; Tuyaerts S; Michiels A; Straetman L; Heirman C; De Greef C; Van Der Bruggen P; Thielemans K
    Mol Ther; 2004 Oct; 10(4):768-79. PubMed ID: 15451461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
    Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
    J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes in cancer immunotherapy: preclinical data.
    Andre F; Andersen M; Wolfers J; Lozier A; Raposo G; Serra V; Ruegg C; Flament C; Angevin E; Amigorena S; Zitvogel L
    Adv Exp Med Biol; 2001; 495():349-54. PubMed ID: 11774591
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
    Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
    J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.